Francis Chou - Chou Associates Management 13F Activity & Position Changes (Q4 2019)

According to the SEC 13F filed on Aug 12, 2026, the Chou Associates Management portfolio showed several notable changes in holdings as of quarter-end Dec 31, 2019. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q4 2019, the filing reported:

New Buys - None reported

Increases - None reported

Reductions - Bank of America Corporation, Bausch Health Companies Inc., DaVita Inc., Wells Fargo & Company

Complete Exits - Teva Pharmaceutical Industries

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q4 2019	BAC Bank of America Corporation	Bank of America Corporation	Sell	-65,000	-69.6%	$999.00	28,376
Q4 2019	BHC Bausch Health Companies Inc.	Bausch Health Companies Inc.	Sell	-30,000	-1.8%	$48.44K	1,618,992
Q4 2019	DVA DaVita Inc.	DaVita Inc.	Sell	-20,000	-16.6%	$7.56K	100,743
Q4 2019	TEVA Teva Pharmaceutical Industries	Teva Pharmaceutical Industries	Sell - Position Exit	-15,000	-100.0%	$0.00	-
Q4 2019	WFC Wells Fargo & Company	Wells Fargo & Company	Sell	-130,000	-38.3%	$11.27K	209,542